Milatuzumab-Doxorubicin Antibody-Drug Conjugate

Definition 1

An immunoconjugate consisting of milatuzumab, a humanized monoclonal antibody against CD74, conjugated to the anthracycline antibiotic doxorubicin with potential antineoplastic activity. The milatuzumab moiety of this ADC selectively binds to CD74 on tumor cell surfaces; upon internalization, the doxorubicin moiety is released, where it intercalates between base pairs in the DNA helix and inhibits topoisomerase II, thereby preventing DNA replication and increasing double-strand breakage. As a result, this agent may inhibit the proliferation of cancer cells that overexpress CD74. CD74, an integral membrane protein and tumor associated antigen (TAA), is overexpressed in certain cancer cells and promotes survival in rapidly proliferating tumor cells. (NCI Thesaurus)

Definition 2

A substance being studied in the treatment of multiple myeloma and several other types of cancer. It binds to CD74, a protein on the surface of myeloma cells and certain other types of cells. It may help kill cancer cells. IMMU-110 is a type of monoclonal antibody. (NCI Dictionary)

YOU MAY ALSO LIKE

Milatuzumab

A substance being studied in the treatment of multiple myeloma and several other types of cancer. It binds to CD74, a protein…

Mil

A unit of length equal to one thousandth of an international inch or 25.4 microns; used predominantly to specify thickness.

Mikulicz Disease

A rare, persistent and bilateral enlargement of the lacrinmal and salivary glands associated with lymphocytic infiltration of the affected glands. It…

Migratory Worker

An individual who moves from one location to another location within or outside of their homeland for work.

Migration of Medical Device or Device Component

Issue associated with an undesired movement of device and/or device components, related to its movement away from or dislodging from a…

Migration Assay

An in vitro assay in which cultured cells are monitored and analyzed for their ability to move into an acellular area of…